Glutathione attenuates nitric oxide-induced retinal lipid and protein changes

Ophthalmic and Physiological Optics

Volumn 35, Issue 2, 2015, Pages 135-146

  Siu, Andrew W ^a   Shan, Sze Wan ^a   Li, King Kit ^a   Lam, Hiu Yan ^a   Fung, Man Yee ^a   Li, Ka Ki ^a   To, Chi Ho ^a,b   Do, Chi Wai ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Glutathione; Lipid; Nitric oxide; Protein; Retina

Indexed keywords

EYE PROTEIN; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ANIMAL; DISEASE MODEL; DRUG EFFECTS; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; PIG; RETINA;

ANIMALS; DISEASE MODELS, ANIMAL; EYE PROTEINS; GLUTATHIONE; LIPID PEROXIDATION; MALONDIALDEHYDE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXIDATIVE STRESS; RETINA; SWINE;

EID: 84924501769     PISSN: 02755408     EISSN: 14751313     Source Type: Journal    
DOI: 10.1111/opo.12198     Document Type: Article

References (66)

1. Dortch-Carnes J & Russell KR. Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide. Pharmacology 2006; 77: 17-24.
2. Sugiyama T, Oku H, Ikari S & Ikeda T. Effect of nitric oxide synthase inhibitor on optic nerve head circulation in conscious rabbits. Invest Ophthalmol Vis Sci 2000; 41: 1149-1152.
3. Dawson VL, Dawson TM, Bartley DA, Uhl GR & Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993; 13: 2651-2661.
4. Siu AW & To CH. Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro. Clin Exp Optom 2002; 85: 378-382.
5. Murayama K, Yoneya S, Miyauchi O, Adachi-Usami E & Nishikawa M. Fish oil (polyunsaturated fatty acid) prevents ischemic-induced injury in the mammalian retina. Exp Eye Res 2002; 74: 671-676.
6. Daemen FJM. Vertebrate rod outer segment membranes. Biochim Biophys Acta 1973; 300: 255-288.
7. Anderson RE & Maude MB. Phospholipids of bovine outer segments. Biochemistry 1970; 9: 3624-3628.
8. Liu Q, Ju WK, Crowston JG et al. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci 2007; 48: 4580-4589.
9. Sharma A, Sharma R, Chaudhary P et al. 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells. Arch Biochem Biophys 2008; 480: 85-94.
10. Neufeld AH, Hernandez MR & Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol 1997; 115: 497-503.
11. Neufeld AH, Sawada A & Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 1999; 96: 9944-9948.
12. Shareef S, Sawada A & Neufeld AH. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest Ophthalmol Vis Sci 1999; 40: 2884-2891.
13. Siu AW, Leung MC, To CH, Siu FK, Ji JZ & So KF. Total retinal nitric oxide production is increased in intraocular pressure-elevated rats. Exp Eye Res 2002; 75: 401-406.
14. Aslan M, Cort A & Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic Biol Med 2008; 45: 367-376.
15. Wu GS, Zhang J & Rao NA. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 1997; 38: 1333-1339.
16. Siu AW, Lau MK, Cheng JS et al. Glutamate-induced retinal lipid and protein damage: the protective effects of catechin. Neurosci Lett 2008; 432: 193-197.
17. Mozaffarieh M, Grieshaber MC, Orgul S & Flammer J. The potential value of natural antioxidative treatment in glaucoma. Surv Ophthalmol 2008; 53: 479-505.
18. Burstedt MS, Ristoff E, Larsson A & Wachtmeister L. Rod-cone dystrophy with maculopathy in genetic glutathione synthetase deficiency: a morphologic and electrophysiologic study. Ophthalmology 2009; 116: 324-331.
19. Liang FQ, Alssadi R, Morehead P, Awasthi YC & Godley BF. Enhanced expression of glutathione-S-transferase A1-1 protects against oxidative stress in human retinal pigment epithelial cells. Exp Eye Res 2005; 80: 113-119.
20. Haq E, Rohrer B, Nath N, Crosson CE & Singh I. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis. J Ocul Pharmacol Ther 2007; 23: 221-231.
21. Ganea E & Harding JJ. Glutathione-related enzymes and the eye. Curr Eye Res 2006; 31: 1-11.
22. Beckman JS & Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 1993; 21: 330-334.
23. Salgo MG, Squadrito GL & Pryor WA. Peroxynitrite causes apoptosis in rat thymocytes. Biochem Biophys Res Commun 1995; 215: 1111-1118.
24. Murphy MP. Nitric oxide and cell death. Biochim Biophys Acta 1999; 1411: 401-414.
25. Pigeolet E & Remacle J. Susceptibility of glutathione peroxidase to proteolysis after oxidative alteration by peroxides and hydroxyl radicals. Free Radic Biol Med 1991; 11: 191-195.
26. Garcia JJ, Reiter RJ, Guerrero JM et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408: 297-300.
27. Edward DP, Lam TT, Shahinfar S, Li J & Tso MO. Amelioration of light-induced retinal degeneration by a calcium overload blocker. Flunarizine. Arch Ophthalmol 1991; 109: 554-562.
28. Siu AW, Reiter RJ & To CH. The efficacy of vitamin E and melatonin as antioxidants against lipid peroxidation in rat retinal homogenates. J Pineal Res 1998; 24: 239-244.
29. Schweizer FE, Dresbach T, DeBello WM, O'Connor V, Augustine GJ & Betz H. Regulation of neurotransmitter release kinetics by NSF. Science 1998; 279: 1203-1206.
30. Percipalle P. Co-transcriptional nuclear actin dynamics. Nucleus 2013; 4: 43-52.
31. Cortelazzo A, De Felice C, Pecorelli A et al. Beta-actin deficiency with oxidative posttranslational modifications in Rett syndrome erythrocytes: insights into an altered cytoskeletal organization. PLoS ONE 2014; 9: e93181.
32. Dalle-Donne I, Giustarini D, Rossi R, Colombo R & Milzani A. Reversible S-glutathionylation of Cys374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 2003; 34: 23-32.
33. Wong SW, Sun S, Cho M, Lee KK & Mak AF. H2O2 exposure affects myotube stiffness and actin filament polymerization. Ann Biomed Eng 2014; DOI: 10.1007/s10439-014-1178-2. [Epub ahead of print]
34. Johansson M & Lundberg M. Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochem 2007; 8: 26.
35. Anderson PJ. The structure and amount of tubulin in cells and tissues. J Biol Chem 1979; 254: 2168-2171.
36. Fournier AE & McKerracher L. Tubulin expression and axonal transport in injured and regenerating neurons in the adult mammalian central nervous system. Biochem Cell Biol 1995; 73: 659-664.
37. Landino LM, Hasan R, McGaw A et al. Peroxynitrite oxidation of tubulin sulfhydryls inhibits microtubule polymerization. Arch Biochem Biophys 2002; 398: 213-220.
38. Dalle-Donne I, Rossi R, Giustarini D, Colombo R & Milzani A. Actin S-glutathionylation: evidence against a thiol-disulphide exchange mechanism. Free Radic Biol Med 2003; 35: 1185-1193.
39. Landino LM, Moynihan KL, Todd JV & Kennett KL. Modulation of the redox state of tubulin by the glutathione/glutaredoxin reductase system. Biochem Biophys Res Commun 2004; 314: 555-560.
40. Sultana R, Reed T, Perluigi M, Coccia R, Pierce WM & Butterfield DA. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study. J Cell Mol Med 2007; 11: 839-851.
41. Rosenblat M & Aviram M. Paraoxonases role in the prevention of cardiovascular diseases. BioFactors 2009; 35: 98-104.
42. Costa LG, Tait L, de Laat R et al. Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of neuroprotection? Neurochem Res 2013; 38: 1809-1818.
43. Brandes N, Schmitt S & Jakob U. Thiol-based redox switches in eukaryotic proteins. Antioxid Redox Signal 2009; 11: 997-1014.
44. Wood ZA, Poole LB, Hantgan RR & Karplus PA. Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins. Biochemistry 2002; 41: 5493-5504.
45. Peng Y, Yang PH, Guo Y et al. Catalase and peroxiredoxin 5 protect Xenopus embryos against alcohol-induced ocular anomalies. Invest Ophthalmol Vis Sci 2004; 45: 23-29.
46. Moreira EF, Kantorow M & Rodriguez IR. Peroxiredoxin 3 (PDRX3) is highly expressed in the primate retina especially in blue cones. Exp Eye Res 2008; 86: 452-455.
47. Osborne NN, Li GY, Ji D, Mortiboys HJ & Jackson S. Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J Neurochem 2008; 105: 2013-2028.
48. Mitsumoto A, Takanezawa Y, Okawa K, Iwamatsu A & Nakagawa Y. Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radic Biol Med 2001; 30: 625-635.
49. Saccà SC, Pascotto A, Camicione P, Capris P & Izzotti A. Oxidative damage in the human trabecular meshwork: clinical correlation in patient with primary open-angle glaucoma. Arch Ophthalmol 2005; 123: 548-563.
50. Koss MC. Functional role of nitric oxide in regulation of ocular blood flow. Eur J Pharmacol 1999; 374: 161-174.
51. Schmetterer L, Krejcy K, Kastner J et al. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res 1997; 64: 305-312.
52. Cleary C, Buckley CH, Henry E, McLoughlin P, O'Brien C & Hadoke PWF. Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye. Br J Ophthalmol 2005; 89: 223-228.
53. Sacca S. Nitric oxide as a mediator of glaucoma pathogenesis. Med Sci Monit 2002; 8: LE33-LE34.
54. Toda N & Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007; 26: 205-208.
55. Beckman JS & Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.
56. Husain S, Abdul Y, Singh S, Ahmad A & Husain M. Regulation of Nitric Oxide Production by d-Opioid Receptors during Glaucomatous Injury. PLoS ONE 2014; 9: e110397.
57. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther 1992; 260: 956-965.
58. Stamer WD, Lei Y, Boussommier-Calleja A, Overby DR & Ethier CR. eNOS, a pressure-dependent regulator of intraocular pressure. Invest Ophthalmol Vis Sci 2011; 52: 9438-9444.
59. Cavet ME, Vittitow JL, Impagnatiello F, Ongini E & Bastia E. Nitric oxide (NO): an emerging target for the treatment of glaucoma. Invest Ophthalmol Vis Sci 2014; 55: 5005-5015.
60. Emam WA, Zidan HE, Abdulhalim BE, Dabour SA, Ghali MA & Kamal AT. Endothelial nitric oxide synthase polymorphisms and susceptibility to high-tension primary open-angle glaucoma in an Egyptian cohort. Mol Vis 2014; 20: 804-811.
61. Awadalla MS, Thapa SS, Hewitt AW, Craig JE & Burdon KP. Association of eNOS polymorphisms with primary angle-closure glaucoma. Invest Ophthalmol Vis Sci 2013; 54: 2108-2114.
62. Bagnis A, Izzotti A, Centofanti M & Saccà SC. Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma. Exp Eye Res 2012; 103: 55-62.
63. Levy DI, Sucher NJ & Lipton SA. Glutathione prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. NeuroReport 1991; 2: 345-347.
64. Ostwald P, Goldstein IM, Pachnanda A & Roth S. Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci 1995; 36: 2396-2403.
65. Lam TT & Tso MO. Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats. Res Commun Mol Pathol Pharmacol 1996; 92: 329-340.
66. Sanz MM, Johnson LE, Ahuja S, Ekstrom PA, Romero J & van Veen T. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience 2007; 145: 1120-1129.